Comparison of Half and Full Doses of an MF59-adjuvanted Cell Culture-Derived a/H1N1v Vaccine in Japanese Children
Advances in Therapy - United States
doi 10.1007/s12325-010-0043-4
Full Text
Open PDFAbstract
Available in full text
Date
June 25, 2010
Authors
Publisher
Springer Science and Business Media LLC